Fundraising Fox

Arthrosi Therapeutics

Laguna Hills, US · Founded 2017 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

Arthrosi Therapeutics was founded in 2017 by Litain Yeh and Shunqi Yan.

LY
Litain YehCo-founder
SY
Shunqi YanCo-founder
RO
Robert OrrNamed on SEC filing
YZ
Yiwei ZongNamed on SEC filing
JF
Jianfeng FangNamed on SEC filing

Board

ZM
Zhang MingyuanBoard director
CY
Chaohua YuanBoard director
XW
Xiaodong WangBoard director
HL
Hanxiong LiBoard director
TH
Thomas HuangBoard director
XX
Xin XieBoard director
JL
John LeamanBoard director

Investors · 2

HM Venture PartnersSan Francisco
Highlight Capitalreported · 2 sourcesNanjin · $2.8M – $74M

Reported raises · per SEC filings

Form D private placements

$132.9M disclosed across 8 rounds · 2018–2025

▶$60.9MraisedJun 2025 · 13 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Zhang MingyuanDirector
  • Chaohua YuanDirector
  • Xiaodong WangDirector
  • John LeamanDirector
  • Hanxiong LiDirector
  • Thomas HuangDirector
  • Xin XieDirector
  • Litain YehExecutive Officer, Director, Promoter
  • Shunqi YanExecutive Officer, Director, Promoter
Offering amount
$153.1M
Amount sold
$60.9M
First sale
Jun 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7MraisedJan 2024 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Xin XieDirector
  • Chaohua YuanDirector
  • James McKayDirector
  • Xiaodong WangDirector
  • Hanxiong LiDirector
  • Shunqi YanExecutive Officer, Director, Promoter
  • Litain YehExecutive Officer, Director, Promoter
  • Xiaojia CaiDirector
Offering amount
$75M
Amount sold
$7M
First sale
Sep 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedMar 2023 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Yiwei ZongDirector
  • Xiaojia CaiDirector
  • Litain YehExecutive Officer, Director, Promoter
  • Shunqi YanExecutive Officer, Director, Promoter
  • Xin XieDirector
  • Hanxiong LiDirector
  • James McKayDirector
Offering amount
$20M
Amount sold
$15M
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$26MraisedNov 2021 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Hanxiong LiDirector
  • James MackayDirector
  • Cynthia CaiDirector
  • Xie XinDirector
  • Litain YehExecutive Officer, Director, Promoter
  • Shunqi YanExecutive Officer, Director, Promoter
  • Yiwei ZhongDirector
Offering amount
$30M
Amount sold
$26M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$220KraisedNov 2021 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Litain YehExecutive Officer, Director, Promoter
  • Shunqi YanExecutive Officer, Director, Promoter
  • Xie XinDirector
  • Li HanxiongDirector
  • Cynthia CaiDirector
  • James MackayDirector
  • Yiwei ZhongDirector
Offering amount
$220K
Amount sold
$220K
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.5MraisedJun 2020 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Litain YehExecutive Officer, Director, Promoter
  • Shunqi YanExecutive Officer, Director, Promoter
  • Yiwei ZongDirector
  • Robert OrrExecutive Officer, Director, Promoter
  • Jianhua CaiDirector
Offering amount
$20M
Amount sold
$8.5M
First sale
May 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11MraisedJan 2019 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Yiwei ZongDirector
  • Litain YehExecutive Officer, Director, Promoter
  • Shunqi YanExecutive Officer, Director, Promoter
  • Robert OrrExecutive Officer, Director, Promoter
  • Jianhua CaiDirector
Offering amount
$11M
Amount sold
$11M
First sale
Oct 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.3MraisedJun 2018 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert OrrExecutive Officer, Director, Promoter
  • Shunqi YanExecutive Officer, Director, Promoter
  • Litain YehExecutive Officer, Director, Promoter
  • Yiwei ZongDirector
  • Jianfeng FangDirector
Offering amount
$4.3M
Amount sold
$4.3M
First sale
Jan 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Arthrosi gains $153m for development of gout therapyfinance.yahoo.com · Oct 2025Arthrosi Secures $153M in Series E Fundingfinsmes.com · Oct 2025Arthrosi snags $153M in pursuit of a new gout drug | BioPharma Divebiopharmadive.com · Oct 2025Arthrosi Secures $153 Million in Series E Financing to Complete Pivotal Development of Pozdeutinurad for the Treatment of Gout and Tophaceous Goutprnewswire.com · Oct 2025Arthrosi raises $153M, fueling dash toward phase 3 gout data in 2026fiercebiotech.com · Oct 2025Arthrosi Therapeutics Raises $75M in Series D Fundingfinsmes.com · Jul 2023

Frequently asked questions

Who founded Arthrosi Therapeutics?
Arthrosi Therapeutics was founded by Litain Yeh, Shunqi Yan in 2017.
Who are Arthrosi Therapeutics's investors?
Arthrosi Therapeutics's investors include HM Venture Partners, Highlight Capital.
How much funding has Arthrosi Therapeutics raised?
Arthrosi Therapeutics has disclosed $132.9M raised across 8 rounds.
Where is Arthrosi Therapeutics headquartered?
Arthrosi Therapeutics is headquartered in Laguna Hills, US.